- Home
- CLWT vs MYNZ Comparison
CLWT vs MYNZ Comparison
Compare CLWT & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLWT
- MYNZ
- Stock Information
- Founded
- CLWT 1971
- MYNZ 2021
- Country
- CLWT Hong Kong
- MYNZ Germany
- Employees
- CLWT N/A
- MYNZ N/A
- Industry
- CLWT Professional and commerical equipment
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- CLWT Consumer Discretionary
- MYNZ Health Care
- Exchange
- CLWT Nasdaq
- MYNZ Nasdaq
- Market Cap
- CLWT 9.4M
- MYNZ 7.9M
- IPO Year
- CLWT 1997
- MYNZ 2021
- Fundamental
- Price
- CLWT $1.50
- MYNZ $1.60
- Analyst Decision
- CLWT
- MYNZ Buy
- Analyst Count
- CLWT 0
- MYNZ 2
- Target Price
- CLWT N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- CLWT 81.9K
- MYNZ 387.7K
- Earning Date
- CLWT 04-30-2025
- MYNZ 09-26-2025
- Dividend Yield
- CLWT N/A
- MYNZ N/A
- EPS Growth
- CLWT N/A
- MYNZ N/A
- EPS
- CLWT 0.10
- MYNZ N/A
- Revenue
- CLWT $15,383,000.00
- MYNZ $659,935.00
- Revenue This Year
- CLWT N/A
- MYNZ $26.06
- Revenue Next Year
- CLWT N/A
- MYNZ $4.97
- P/E Ratio
- CLWT $15.03
- MYNZ N/A
- Revenue Growth
- CLWT N/A
- MYNZ N/A
- 52 Week Low
- CLWT $1.01
- MYNZ $1.28
- 52 Week High
- CLWT $1.66
- MYNZ $16.04
- Technical
- Relative Strength Index (RSI)
- CLWT 37.98
- MYNZ 35.56
- Support Level
- CLWT $1.34
- MYNZ $1.55
- Resistance Level
- CLWT $1.45
- MYNZ $1.73
- Average True Range (ATR)
- CLWT 0.07
- MYNZ 0.12
- MACD
- CLWT -0.02
- MYNZ -0.01
- Stochastic Oscillator
- CLWT 0.00
- MYNZ 5.56
About CLWT Euro Tech Holdings Company Limited
Euro Tech Holdings Co Ltd is a distributor and manufacturer of technology instruments as well as an environmental engineering services provider. It is engaged in the marketing and trading of water and wastewater related process control, analytical and testing instruments, disinfection equipment, supplies, and related automation systems. There are two operating segments of the company. The Trading and manufacturing segment, which is the key revenue driver, includes distribution of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies and power generation equipment. The Engineering segment includes water and waste-water treatment engineering and air pollution control business. The majority of the revenue is generated from Hong Kong.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.